BioAge Labs (BIOA) FY Conference June 09, 2025 03:20 PM ET Speaker0 Great. Good afternoon, everyone. Thank you so much for joining us. I'm Salveen Richter, biotechnology analyst at Goldman Sachs, and it's a pleasure to have the BioAge team with us. With us, we have Kristen Fortney, cofounder and CEO and Deb Goldstein, CFO. So to to start here, you know, in the context of the news, though, that's played out since the IPO, Maybe level set us with where you stand today in terms of strategy, pipeline, and your ...